Blasts Under 15 Percent of Bone Marrow Nucleated Cells
1 clinical trials · Condition
◉ Watch Blasts Under 15 Percent of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure (NCT02906696) | M.D. Anderson Cancer Center | 2016-10-28 |
Track Blasts Under 15 Percent of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.